Free Trial
NASDAQ:CDXS

Codexis (CDXS) Stock Price, News & Analysis

Codexis logo
$2.76 -0.05 (-1.78%)
Closing price 07/3/2025 03:43 PM Eastern
Extended Trading
$2.67 -0.09 (-3.26%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Codexis Stock (NASDAQ:CDXS)

Key Stats

Today's Range
$2.69
$2.91
50-Day Range
$2.22
$2.81
52-Week Range
$1.90
$6.08
Volume
1.47 million shs
Average Volume
743,668 shs
Market Capitalization
$228.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
Consensus Rating
Moderate Buy

Company Overview

Codexis Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

CDXS MarketRank™: 

Codexis scored higher than 59% of companies evaluated by MarketBeat, and ranked 418th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Codexis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Codexis has received no research coverage in the past 90 days.

  • Read more about Codexis' stock forecast and price target.
  • Earnings Growth

    Earnings for Codexis are expected to grow in the coming year, from ($0.77) to ($0.66) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Codexis is -2.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Codexis is -2.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Codexis has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Codexis' valuation and earnings.
  • Percentage of Shares Shorted

    7.84% of the float of Codexis has been sold short.
  • Short Interest Ratio / Days to Cover

    Codexis has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Codexis has recently increased by 17.56%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Codexis does not currently pay a dividend.

  • Dividend Growth

    Codexis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.84% of the float of Codexis has been sold short.
  • Short Interest Ratio / Days to Cover

    Codexis has a short interest ratio ("days to cover") of 7.3.
  • Change versus previous month

    Short interest in Codexis has recently increased by 17.56%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 1 people have searched for CDXS on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Codexis to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Codexis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Codexis is held by insiders.

  • Percentage Held by Institutions

    78.54% of the stock of Codexis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Codexis' insider trading history.
Receive CDXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Codexis and its competitors with MarketBeat's FREE daily newsletter.

CDXS Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Q1 2025 Codexis Inc Earnings Call
See More Headlines

CDXS Stock Analysis - Frequently Asked Questions

Codexis' stock was trading at $4.77 at the start of the year. Since then, CDXS shares have decreased by 42.1% and is now trading at $2.76.

Codexis, Inc. (NASDAQ:CDXS) released its quarterly earnings results on Wednesday, May, 14th. The biotechnology company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.05. The biotechnology company earned $7.54 million during the quarter, compared to analysts' expectations of $10.38 million. Codexis had a negative trailing twelve-month return on equity of 118.47% and a negative net margin of 149.47%.
Read the conference call transcript
.

Shares of CDXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Codexis investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), Walt Disney (DIS) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/14/2025
Today
7/06/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CDXS
Employees
250
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.00
High Stock Price Target
$11.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+298.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.28 million
Net Margins
-149.47%
Pretax Margin
-149.40%

Debt

Sales & Book Value

Annual Sales
$59.35 million
Price / Cash Flow
N/A
Book Value
$0.82 per share
Price / Book
3.37

Miscellaneous

Free Float
81,105,000
Market Cap
$228.67 million
Optionable
Optionable
Beta
2.52
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:CDXS) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners